HLK Pharmacin - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Bitcoin $114,128.03 -0.72%
Ethereum $3,625.40 -1.68%
BNB $763.66 -0.14%
Optimism $0.66 -3.81%
Arbitrum $0.39 -3.52%
Solana $163.73 -4.10%
Polygon $0.22 +2.77%
Cosmos $4.20 -1.59%
Avalanche $22.02 -3.38%

Bitcoin $114,128.03 -0.72%
Ethereum $3,625.40 -1.68%
BNB $763.66 -0.14%
Optimism $0.66 -3.81%
Arbitrum $0.39 -3.52%
Solana $163.73 -4.10%
Polygon $0.22 +2.77%
Cosmos $4.20 -1.59%
Avalanche $22.02 -3.38%

HLK Pharmacin

company

Summary
Funding Rounds
Investors

About

HLK Pharmacin is committed to improving patient outcomes through the development of best-in-class therapeutics.

1 - 10

Highlights

Details

Last Funding Type: Series B
Industries: Pharmaceutical
Founded date: Jan 1, 2011
Number Of Employee: 1 - 10
Operating Status: Active

Funding Rounds

Number of Funding Rounds

Total Funding Amount

1

—

HLK Pharmacin has raised a total of — in funding over 2 rounds. Their latest funding was raised on Aug 31, 2021 from a Series B round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Aug 31, 2021	Series B	—	2	—	—	Detail

Investors

Number of Lead Investors

Number of Investors

—

2

HLK Pharmacin is funded by 2 investors. Qingdao Medicine and DaYou Capital are the most recent investors.

Investor Name	Lead Investor	Funding Round
Qingdao Medicine	—	Series B
DaYou Capital	—	Series B